tetrahydrocurcumin has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avtanski, D; Hadzi-Petrushev, N; Li, C; Mitrokhin, V; Mladenov, M; Wang, F; Wang, S; Zhang, L | 1 |
| Gong, X; Li, F; Li, Y; Ma, X; Pan, Y; Tang, H; Wang, J; Yuan, J; Zhang, Y; Zhao, J; Zhao, Y | 1 |
| Chen, YQ; Guo, XY; Li, CW; Li, Q; Shi, YL; Sun, L; Wu, YF; Xu, L; Yang, Y; Ye, XY; Zuo, X | 1 |
| Dai, Y; Geng, F; Li, L; Wang, J; Wang, S; Xiao, Y; Xu, Y; Zhao, J | 1 |
| Bangash, M; Dang, A; Khazaeli, M; Lau, WL; Manekia, K; Savoj, J; Singh, B; Thakurta, RG; Vaziri, ND | 1 |
| Chen, BL; Chen, YQ; Li, CW; Li, LY; Liu, WL; Ma, BH; Wan, JB; Wu, YF; Yang, Y; Yu, SF; Zeng, QX; Zhou, YT | 1 |
| Donpunha, W; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Sangartit, W; Shibahara, S | 1 |
| Cai, C; Lin, B; Lin, Y; Lu, H; Yu, H; Zhu, X | 1 |
| Murugan, P; Pari, L | 1 |
| Rajeswari, A; Sabesan, M | 1 |
1 review(s) available for tetrahydrocurcumin and Disease Models, Animal
| Article | Year |
|---|---|
Tetrahydrocurcumin-Related Vascular Protection: An Overview of the Findings from Animal Disease Models.
Topics: Animals; Curcumin; Disease Models, Animal; Endothelial Cells; Humans; Hypertension; Mice; Vascular Endothelial Growth Factor A | 2022 |
1 trial(s) available for tetrahydrocurcumin and Disease Models, Animal
| Article | Year |
|---|---|
Tetrahydrocurcumin mitigates acute hypobaric hypoxia-induced cerebral oedema and inflammation through the NF-κB/VEGF/MMP-9 pathway.
Topics: Altitude Sickness; Animals; Brain Edema; Cell Hypoxia; Curcumin; Disease Models, Animal; Humans; Inflammation; Male; Mice; NF-kappa B; Vascular Endothelial Growth Factor A | 2020 |
8 other study(ies) available for tetrahydrocurcumin and Disease Models, Animal
| Article | Year |
|---|---|
Supplementation with Tetrahydrocurcumin Enhances the Therapeutic Effects of Dexamethasone in a Murine Model of Allergic Asthma.
Topics: Allergens; Animals; Anti-Asthmatic Agents; Asthma; Curcuma; Curcumin; Dexamethasone; Dietary Supplements; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Ovalbumin; Th2 Cells | 2020 |
Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line; Curcumin; Cyclin D2; Disease Models, Animal; Down-Regulation; Hippocampus; Humans; MAP Kinase Signaling System; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Proteomics; ras Proteins; Signal Transduction; Up-Regulation | 2021 |
Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats.
Topics: Animals; Antioxidants; Cardiomegaly; Curcumin; Disease Models, Animal; Female; Fibrosis; Kidney; Kidney Function Tests; Nephrectomy; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2018 |
Tetrahydrocurcumin, a major metabolite of curcumin, ameliorates allergic airway inflammation by attenuating Th2 response and suppressing the IL-4Rα-Jak1-STAT6 and Jagged1/Jagged2 -Notch1/Notch2 pathways in asthmatic mice.
Topics: Allergens; Animals; Asthma; Biomarkers; Curcumin; Cytokines; Disease Models, Animal; Female; Inflammation Mediators; Jagged-1 Protein; Jagged-2 Protein; Janus Kinase 1; Leukocytes; Mice; Oxidative Stress; Receptor, Notch1; Receptor, Notch2; Receptors, Cell Surface; Signal Transduction; STAT6 Transcription Factor; Th2 Cells | 2018 |
Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice.
Topics: Administration, Oral; Animals; Baroreflex; Curcumin; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hypertension; Iron Chelating Agents; Iron Overload; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Pyridones | 2016 |
Suppression of GRASP65 phosphorylation by tetrahydrocurcumin protects against cerebral ischemia/reperfusion injury via ERK signaling.
Topics: Animals; Apoptosis; Brain Infarction; Brain Ischemia; Carrier Proteins; Curcumin; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Intracellular Signaling Peptides and Proteins; Male; Malondialdehyde; Membrane Proteins; Mice; Neurons; Neuroprotective Agents; Reperfusion Injury; Signal Transduction; Superoxide Dismutase | 2016 |
Tetrahydrocurcumin: effect on chloroquine-mediated oxidative damage in rat kidney.
Topics: Administration, Oral; Animals; Antioxidants; Chemoprevention; Chloroquine; Creatinine; Curcumin; Disease Models, Animal; Female; Kidney; Lipid Peroxidation; Nephritis; Oxidative Stress; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Urea | 2006 |
Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Curcumin; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Flavonoids; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neurons; Parkinson Disease; Phenols; Polyphenols | 2008 |